Skip to content
Biodatica
Start free

Investigator

Yadong Huang

J. DAVID GLADSTONE INSTITUTES · funded by NIA

Companies
3

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$5.4M

Summed across those awards.

First award
Aug 1, 2021

Latest Dec 15, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Study Alzheimer's Disease Protective APOE Variants

    $941k

    Dec 15, 2023NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11235906 (opens the source filing in a new tab)

  2. R01

    Develop AD Connectivity Maps with Human iPSC-Derived Brain Cells and their Use

    $923k

    Sep 1, 2022NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11089370 (opens the source filing in a new tab)

  3. R01

    Develop AD Connectivity Maps with Human iPSC-Derived Brain Cells and their Use

    $944k

    Sep 1, 2022NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11333756 (opens the source filing in a new tab)

  4. R01

    Study Susceptibility and Resistance to ApoE4 in Alzheimer's Disease

    $861k

    Jul 1, 2022NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11297482 (opens the source filing in a new tab)

  5. P01

    Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease

    $917k

    Aug 15, 2021NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11166569 (opens the source filing in a new tab)

  6. R01

    Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's Disease

    $801k

    Aug 1, 2021NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11115632 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources